Amylyx Pharmaceuticals, Inc. (AMLX) vs Neogen Corporation (NEOG)
A side-by-side comparison of Amylyx Pharmaceuticals, Inc. and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMLX
Amylyx Pharmaceuticals, Inc.
$27.75HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
NEOG
Neogen Corporation
$12.19HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — AMLX vs NEOG
growth of $100 · dividends reinvested · last 5yAMLX +53.7% (+9.0%/yr)NEOG -71.3% (-22.1%/yr)AMLX compounded faster over this window
Log scale — wide-divergence pair
AMLX NEOG
AMLX vs NEOG: by the numbers
- •AMLX is the larger company ($3.09B vs $2.66B market cap).
- •Both run net losses; AMLX's is the smaller (0.00% vs -0.91% net margin).
Metrics side by side
Valuation
| Metric | AMLX | NEOG |
|---|---|---|
| Forward P/E | N/A | 39.33 |
| P/S ratio | N/A | 3.05 |
| P/B ratio | 12.90 | 1.27 |
| EV / EBITDA | N/A | 32.59 |
Profitability
| Metric | AMLX | NEOG |
|---|---|---|
| Gross margin | 0.00% | 46.93% |
| Operating margin | 0.00% | -2.49% |
| Net margin | 0.00% | -0.91% |
| ROE | -63.59% | -0.38% |
| ROIC | -66.60% | -0.68% |
Growth (annualized)
| Metric | AMLX | NEOG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.19% |
| Total return CAGR (5Y) | N/A | -21.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.